This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB02902/identifier/pubchem-substance/
n6http://linked.opendata.cz/resource/drugbank/drug/DB02902/identifier/drugbank/
n11http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB02902/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB02902/identifier/pubchem-compound/

Statements

Subject Item
n2:DB02902
rdf:type
n3:Drug
n3:description
3'-Phosphoadenosine-5'-phosphosulfate. Key intermediate in the formation by living cells of sulfate esters of phenols, alcohols, steroids, sulfated polysaccharides, and simple esters, such as choline sulfate. It is formed from sulfate ion and ATP in a two-step process. This compound also is an important step in the process of sulfur fixation in plants and microorganisms. [PubChem]
n3:group
experimental
owl:sameAs
n11:DB02902 n13:DB02902
dcterms:title
3'-Phosphate-Adenosine-5'-Phosphate Sulfate
adms:identifier
n6:DB02902 n7:46508242 n8:PPS n9:46936522
n3:IUPAC-Name
n4:271B6393-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B6399-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B6398-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B6395-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B6396-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B6397-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B6391-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B638F-363D-11E5-9242-09173F13E4C5 n4:271B6392-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B6390-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B639F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B63A0-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B639A-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B639B-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B639D-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B639C-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B639E-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B63A5-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B63A7-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B63A8-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B63A4-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B63A3-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B63A6-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B6394-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B63A1-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B63A2-363D-11E5-9242-09173F13E4C5